Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicinesMembers leverage AI-powered dataset to accelerate ...

Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive. In a statement Sunday, Illumina ILMN, ...

On July 31, 2025, the United States Department of Justice (DOJ) announced a $9.8 million settlement with Illumina, Inc. (Illumina) to resolve alleged False Claims Act (FCA) violations related to ...

Illumina, Inc., a publicly-traded biotechnology company, agreed to a $9.8 million settlement with the U.S. Department of Justice (DOJ) in response to alleged violations of the False Claims Act (FCA).

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its ...

We recently compiled a list of the 10 Cheap Robotics Stocks To Buy. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other cheap robotic stocks.

Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, ...

Illumina Inc ILMN disclosed in an SEC filing that the Securities and Exchange Commission is the latest government agency investigating the company's $8 billion Grail acquisition. In quarterly 10Q ...

Aug 9 (Reuters) - Illumina Inc (ILMN.O), opens new tab cut annual profit forecast, in a sign that a funding crunch among its biotech and pharmaceutical clients is ...

Alnylam Pharma joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine: San Diego Saturday, September 20, 2025, 12:00 Hrs [IST ...